AbbVie CEO Says New Rules Won't Derail $54B Shire Inversion
Tougher standards for inversion deals introduced by the U.S. government last week threaten to upend controversial tax-motivated M&A plays already on the table, but AbbVie Inc. says a historic $54 billion...To view the full article, register now.
Already a subscriber? Click here to view full article